197 related articles for article (PubMed ID: 11218245)
41. Study on ascitic fluid protein level in cirrhotic patients with spontaneous bacterial peritonitis.
Mustafa MG; Al Mamun MA; Alam AK
Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):41-3. PubMed ID: 20120777
[TBL] [Abstract][Full Text] [Related]
42. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
[TBL] [Abstract][Full Text] [Related]
43. Tuberculous peritonitis in cirrhotic patients: comparison of spontaneous bacterial peritonitis caused by Escherichia coli with tuberculous peritonitis.
Kim NJ; Choo EJ; Kwak YG; Lee SO; Choi SH; Woo JH; Kim YS
Scand J Infect Dis; 2009; 41(11-12):852-6. PubMed ID: 19922068
[TBL] [Abstract][Full Text] [Related]
44. Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.
Kim SU; Kim DY; Lee CK; Park JY; Kim SH; Kim HM; Choi EH; Kim S; Han KH; Chon CY; Ahn SH
J Gastroenterol Hepatol; 2010 Jan; 25(1):122-8. PubMed ID: 19845823
[TBL] [Abstract][Full Text] [Related]
45. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
[TBL] [Abstract][Full Text] [Related]
46. Ascitic Calprotectin is a Novel and Accurate Marker for Spontaneous Bacterial Peritonitis.
Fernandes SR; Santos P; Fatela N; Baldaia C; Tato Marinho R; Proença H; Ramalho F; Velosa J
J Clin Lab Anal; 2016 Nov; 30(6):1139-1145. PubMed ID: 27184969
[TBL] [Abstract][Full Text] [Related]
47. The spontaneous bacterial peritonitis in cirrhotic patients. To a new gold standard.
Leandro G; Colloredo Mels G; Minoia M; Manghisi OG; Di Nolfo MA; Moretti GB
Ital J Gastroenterol; 1991; 23(7):416-20. PubMed ID: 1742539
[TBL] [Abstract][Full Text] [Related]
48. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.
Rodríguez-Ramos C; Galan F; Díaz F; Elvira J; Martín-Herrera L; Girón-González JA
Dig Dis Sci; 2001 Aug; 46(8):1668-76. PubMed ID: 11508666
[TBL] [Abstract][Full Text] [Related]
49. The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.
Hanouneh MA; Hanouneh IA; Hashash JG; Law R; Esfeh JM; Lopez R; Hazratjee N; Smith T; Zein NN
J Clin Gastroenterol; 2012 Sep; 46(8):709-15. PubMed ID: 22878533
[TBL] [Abstract][Full Text] [Related]
50. Rapid detection of spontaneous bacterial peritonitis by granulocyte elastase latex immunoassay and reagent strip.
Yamazaki M; Sano R; Kuramoto C; Yoshiji H; Uemura M; Fukui H; Kamiya M; Okamoto Y
Rinsho Byori; 2011 Jun; 59(6):549-58. PubMed ID: 21815476
[TBL] [Abstract][Full Text] [Related]
51. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.
Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Márquez D; Santana F; Pérez-Mateo M; Such J
J Clin Immunol; 2007 Jul; 27(4):438-44. PubMed ID: 17404822
[TBL] [Abstract][Full Text] [Related]
52. Renal impairment after spontaneous bacterial peritonitis: incidence and prognosis.
Perdomo Coral G; Alves de Mattos A
Can J Gastroenterol; 2003 Mar; 17(3):187-90. PubMed ID: 12677269
[TBL] [Abstract][Full Text] [Related]
53. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1β) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis.
Lesińska M; Hartleb M; Gutkowski K; Nowakowska-Duława E
Adv Med Sci; 2014 Mar; 59(1):52-6. PubMed ID: 24797975
[TBL] [Abstract][Full Text] [Related]
54. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Sirinthornpunya S; Luangvichcharoen K
J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
[TBL] [Abstract][Full Text] [Related]
55. [Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].
Hou HR; Pan HH; Li YK; Wei JF; Kang YH; Mao CS; Shang J; Kang Y
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):274-280. PubMed ID: 31082338
[No Abstract] [Full Text] [Related]
56. The role of rifaximine in the prevention of the spontaneous bacterial peritonitis.
Dănulescu RM; Ciobică A; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):315-20. PubMed ID: 24340510
[TBL] [Abstract][Full Text] [Related]
57. Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis.
Parsi MA; Saadeh SN; Zein NN; Davis GL; Lopez R; Boone J; Lepe MR; Guo L; Ashfaq M; Klintmalm G; McCullough AJ
Gastroenterology; 2008 Sep; 135(3):803-7. PubMed ID: 18590731
[TBL] [Abstract][Full Text] [Related]
58. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of spontaneous bacterial peritonitis in asymptomatic inpatients with decompensated liver cirrhosis - a pilot study.
Kasztelan-Szczerbinska B; Słomka M; Celinski K; Serwacki M; Szczerbinski M; Cichoz-Lach H
Adv Med Sci; 2011; 56(1):13-7. PubMed ID: 21536540
[TBL] [Abstract][Full Text] [Related]
60. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.
Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE
Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
